Spero Therapeutics, Inc. (SPRO)
2.31
+0.05
(+2.21%)
USD |
NASDAQ |
Dec 08, 16:00
2.295
-0.02
(-0.65%)
Pre-Market: 20:00
Spero Therapeutics Total Liabilities (Quarterly): 27.68M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Omeros Corp. | 406.18M |
| GeoVax Labs, Inc. | 1.824M |
| Vistagen Therapeutics, Inc. | 14.59M |
| Daré Bioscience, Inc. | 27.89M |
| Hyperion DeFi, Inc. | 12.03M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.17M |
| Shareholders Equity (Quarterly) | 26.49M |
| Debt to Equity Ratio | 0.1265 |
| Current Ratio | 3.834 |
| Net Debt Paydown Yield | 0.30% |